hLife (Aug 2024)
BCMA-CD19 bispecific CAR-T therapy in refractory chronic inflammatory demyelinating polyneuropathy
- Wei Zhang,
- Dan Liu,
- Tao Zhang,
- Jiang Cao,
- Gang Wang,
- Huizhong Li,
- Su Zhou,
- Ruixue Zhang,
- Yuqiao Wang,
- Jinyu Li,
- Zixuan Zhang,
- Hao Chen,
- Yong Zhang,
- Shenyang Zhang,
- Jie Zu,
- Xiaopeng Wang,
- Chuanying Xu,
- Manli Zhou,
- Ming Shi,
- Guiyun Cui,
- Junnian Zheng
Affiliations
- Wei Zhang
- Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, China
- Dan Liu
- Cancer Institute, Xuzhou Medical University, Jiangsu, China; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Jiangsu, China; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, China
- Tao Zhang
- Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, China
- Jiang Cao
- Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, China
- Gang Wang
- Cancer Institute, Xuzhou Medical University, Jiangsu, China; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Jiangsu, China; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, China
- Huizhong Li
- Cancer Institute, Xuzhou Medical University, Jiangsu, China; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Jiangsu, China; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, China
- Su Zhou
- Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, China
- Ruixue Zhang
- Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, China
- Yuqiao Wang
- Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, China
- Jinyu Li
- Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, China
- Zixuan Zhang
- Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, China
- Hao Chen
- Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, China
- Yong Zhang
- Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, China
- Shenyang Zhang
- Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, China
- Jie Zu
- Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, China
- Xiaopeng Wang
- Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, China
- Chuanying Xu
- Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, China
- Manli Zhou
- Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, China
- Ming Shi
- Cancer Institute, Xuzhou Medical University, Jiangsu, China; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Jiangsu, China; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, China; Correspondence:
- Guiyun Cui
- Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, China; Correspondence:
- Junnian Zheng
- Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, China; Correspondence:
- Journal volume & issue
-
Vol. 2,
no. 8
pp. 434 – 438
